SAP30BP is a transcriptional regulatory protein that functions as a binding partner of SAP30, a component of histone deacetylase complexes involved in transcriptional repression. The protein plays a role in regulating mRNA splicing through its association with prespliceosomal components 1 and participates in cyclin-dependent kinase signaling within the spliceosome 2. At the functional level, SAP30BP modulates histone deacetylation and transcriptional activity, mechanisms that extend to stress response pathways in plants 3. In human disease, SAP30BP has emerged as a genetic risk factor for rotator cuff injury. A variant (rs820218) shows association with rotator cuff tears in Amazonian populations, where carriers of the protective A allele demonstrate reduced disease risk 4. While this association warrants further investigation 5, the current evidence suggests it is premature to incorporate SAP30BP polymorphisms into commercial genetic testing for musculoskeletal injury susceptibility. Recent evidence indicates that elevated SAP30BP expression aggravates ferroptosis in diabetic cardiomyopathy by suppressing MFN2 transcription through HDAC1-mediated histone deacetylation, disrupting mitochondrial dynamics and promoting lipid peroxidation 6. These findings identify SAP30BP knockdown as a potential therapeutic strategy for DCM through targeting ferroptosis pathways.